Excited-state intramolecular proton-transfer reaction demonstrating anti-Kasha behavior.

We report unusual photophysical properties observed on two newly designed 3-hydroxychromone derivatives exhibiting the excited-state intramolecular proton transfer (ESIPT) reaction. The efficiency of ESIPT reaction is greatly enhanced upon excitation with high energy quanta to S n (n > 1) levels in low-polarity solvents. Based on detailed analyses of excitation and emission spectra as well as time-resolved emission kinetics we derive that conditions, in which this phenomenon contradicting Kasha's rule is observed, are quite different from that for observation of anti-Kasha emission.

The first tandem, all-exciplex-based WOLED.

Exploiting our recently developed bilayer interface methodology, together with a new wide energy-gap, low LUMO acceptor (A) and the designated donor (D) layers, we succeeded in fabricating an exciplex-based organic light-emitting diode (OLED) systematically tuned from blue to red. Further optimization rendered a record-high blue exciplex OLED with η(ext) of 8%. We then constructed a device structure configured by two parallel blend layers of mCP/PO-T2T and DTAF/PO-T2T, generating blue and yellow exciplex emission, respectively. The resulting device demonstrates for the first time a tandem, all-exciplex-based white-light OLED (WOLED) with excellent efficiencies η(ext): 11.6%, η(c): 27.7 cd A(-1), and η(p): 15.8 ml W(-1) with CIE(0.29, 0.35) and CRI 70.6 that are nearly independent of EL intensity. The tandem architecture and blend-layer D/A (1:1) configuration are two key elements that fully utilize the exciplex delay fluorescence, providing a paragon for the use of low-cost, abundant organic compounds en route to commercial WOLEDs.

Water-soluble noncovalent adducts of the heterometallic copper subgroup complexes and human serum albumin with remarkable luminescent properties.

Novel water-soluble noncovalent adducts of the heterometallic copper subgroup complexes and human serum albumin (HSA) display strong phosphorescence, internalize into HeLa cells and can be used in time-resolved fluorescent imaging.

Novel ambipolar orthogonal donor-acceptor host for blue organic light emitting diodes.

Ambipolar triplet hosts comprising 1,2,4-triazole and carbazole in ortho-positions have been developed. The blue PHOLED has a high current efficiency of 47.1 cd A(-1), power efficiency of 41.2 lm W(-1), and low efficiency roll-off. The high efficiency was attributed to the successful control of π-conjugation through orthogonal arrangement of the substituents so that a wide T1-S0 gap could be maintained.

A new class of sky-blue-emitting Ir(III) phosphors assembled using fluorine-free pyridyl pyrimidine cyclometalates: application toward high-performance sky-blue- and white-emitting OLEDs.

Two pyrimidine chelates with the pyridin-2-yl group residing at either the 5- or 4-positions are synthesized. These chelates are then utilized in synthesizing of a new class of heteroleptic Ir(III) metal complexes, namely [Ir(b5ppm)2(fppz)] (1), [Ir(b5bpm)2(fppz)] (2), [Ir(b4bpm)2(fppz)] (3), and [Ir(b5bpm)(fppz)2] (4), for which the abbreviations b5ppm, b5bpm, b4bpm, and fppz represent chelates derived from 2-t-butyl-5-(pyridin-2-yl)pyrimidine, 2-t-butyl-5-(4-t-butylpyridin-2-yl)pyrimidine, 2-t-butyl-4-(4-t-butylpyridin-2-yl)pyrimidine, and 3-trifluoromethyl-5-(pyridin-2-yl) pyrazole, respectively. The single crystal X-ray structural analyses were executed on 1 to reveal their coordination arrangement around the Ir(III) metal element. The 5-substituted pyrimidine complexes 1, 2, and 4 exhibited the first emission peak wavelength (λmax) located in the range 452-457 nm with high quantum yields, whereas the emission of 3 with 4-substituted pyrimidine was red-shifted substantially to longer wavelength with λmax = 535 nm. These photophysical properties were discussed under the basis of computational approaches, particularly the relationship between emission color and the relative position of nitrogen atoms of pyrimidine fragment. For application, organic light-emitting diodes (OLEDs) were also fabricated using 2 and 4 as dopants, attaining the peak external quantum, luminance, and power efficiencies of 17.9% (38.0 cd/A and 35.8 lm/W) and 15.8% (30.6 cd/A and 24.8 lm/W), respectively. Combining sky blue-emitting 2 and red-emitting [Os(bpftz)2(PPh2Me)2] (5), the phosphorescent white OLEDs were demonstrated with stable pure-white emission at CIE coordinate of (0.33, 0.34), and peak luminance efficiency of 35.3 cd/A, power efficiency of 30.4 lm/W, and external quantum efficiency up to 17.3%.

Highly efficient bilayer interface exciplex for yellow organic light-emitting diode.

A simple three-layer interfacial-type yellow emission exciplex device with an external quantum efficiency as high as 7.7% has been successfully achieved by combining conformation compatible C3-symmetric hole-transporting TCTA and electron-transporting 3P-T2T. The excellent and balanced charge-transporting properties of TCTA and 3P-T2T and the large energy-levels offset (0.8 eV) of TCTA/3P-T2T interface play important roles for the efficient exciplexes formation, which are effectively confined around the interfacial region due to the high triplet energies (2.85 eV) of TCTA and 3P-T2T. The high-performance OLED was believed to be from the effective harvest of exciplex triplet excitons via reverse intersystem crossing process.

Emissive osmium(II) complexes with tetradentate bis(pyridylpyrazolate) chelates.

A tetradentate bis(pyridylpyrazolate) chelate, L, is assembled by connecting two bidentate 3-(trifluoromethyl)-5-(2-pyridyl)pyrazole chelates at the 6 position of the pyridyl fragment with a phenylamido appendage. This chelate was then utilized in the synthesis of three osmium(II) complexes, namely, [Os(L)(CO)2] (4), [Os(L)(PPh2Me)2] (5), and [Os(L)(PPhMe2)2] (6). Single-crystal X-ray structural analyses were executed on 4 and 5 to reveal the bonding arrangement of the L chelate. Phosphine-substituted derivatives 5 and 6 are highly emissive in both solution and the solid state, and their photophysical properties were measured and discussed on the basis of computational approaches. For application, fabrication and analysis of organic light-emitting diodes (OLEDs) were also carried out. The OLEDs using 5 and 6 as dopants exhibit saturated red emission with maximum external quantum efficiencies of 9.8% and 9.4%, respectively, which are higher than that of the device using [Ir(piq)3] as a red-emitting reference sample. Moreover, for documentation, 5 and 6 also achieve a maximum brightness of 19540 cd·m(-2) at 800 mA·cm(-2) (11.6 V) and 12900 cd·m(-2) at 500 mA·cm(-2) (10.5 V), respectively.

Expression of lrwd1 in mouse testis and its centrosomal localization.

The mouse leucine-rich repeats and WD repeat domain containing 1 (lrwd1) gene is located on chromosome 5qG2 and spans over 13 kilobases. It encodes a novel protein of 648-amino acid protein that shares 78.3% amino acid sequence identity with the human LRWD1 protein. We used an oligopeptide as immunogen to generate an anti-lrwd1 antibody in rabbits. Both Northern and Western blot results indicated that the expression of lrwd1 is testis specific. Immunostaining of mouse testis sections detected high levels of lrwd1 signals in the cytoplasm of primary spermatocytes to mature spermatozoa and much weaker signals in spermatogonia. On mature spermatozoa, the anti-lrwd1 antibody stained strongly the connection region between the head and the neck where the centrosome is located. Additional immunostaining and immunoprecipitation showed colocalization and interaction between lrwd1 and γ-tubulin respectively, implicating lrwd1 as a candidate centrosomal protein. These results suggest that lrwd1 may play an important role in spermatogenesis.

Association of spermatogenic failure with decreased CDC25A expression in infertile men.

BACKGROUND: DAZ gene family is crucial for human spermatogenesis that requires the precise co-ordination of cell cycle events. CDC25A is recognized as the downstream substrate of DAZ gene family and is thought to function on the M-phase regulation of cell cycles. We investigated the expression profiles of CDC25A in the testes of infertile men and evaluated the relationship between CDC25A levels and testicular phenotype, clinical hormonal parameters and sperm retrieval results. METHODS: The protein and mRNA transcript levels of CDC25A in the testes of 40 azoospermic men were determined by immunohistochemistry and quantitative real-time-PCR. CDC25A in human spermatozoa was investigated by western blotting and immunofluorescence staining. RESULTS: The CDC25A protein was expressed mainly in spermatocyte, spermatid and spermatozoa. CDC25A transcript levels were significantly decreased (P = 0.0009) in patients with spermatogenic failure, especially in men with meiotic arrest and Sertoli cell-only syndrome. Significantly higher CDC25A transcript levels were detected in patients with successful sperm retrieval than in patients with failed sperm retrieval (P = 0.005). CONCLUSIONS: Decreased CDC25A is associated with spermatogenic failure and failed sperm retrieval in infertile men. Further studies are necessary to explore the functional roles of CDC25A in human spermatozoa.